EPS (Diluted) for Gilead Sciences (GILD)
According to Gilead Sciences's latest reported financial statements, the company's current diluted EPS (TTM) is $6.77. Diluted earnings per share (EPS) is net income divided by the diluted weighted-average shares outstanding over the period. It expresses profit on a per-share basis — the figure investors use to value an individual share — and accounts for potential dilution from options, RSUs, and convertible securities.
Headline TTM above sums the four reported quarters through (reported ). Chart and table below cover the full reported history back to .

GILD
Currently viewingEPS (Diluted)Switch metric
TTM (last 4 quarters)
$6.77
YoY change
+1684.2%
5Y CAGR
+133.6%
Peak year (2015)
$11.91
Latest annual
$6.78
EPS (Diluted) history chart for Gilead Sciences (GILD) from 1990 to 2025
EPS (Diluted) history table for Gilead Sciences (GILD) from 1990 to 2025
| Fiscal year | Period ended | Reported | EPS (Diluted) | YoY |
|---|---|---|---|---|
| 2025 | $6.78 | +1684.2% | ||
| 2024 | $0.38 | -91.6% | ||
| 2023 | $4.50 | +23.6% | ||
| 2022 | $3.64 | -26.2% | ||
| 2021 | $4.93 | +4961.6% | ||
| 2020 | $0.10 | -97.7% | ||
| 2019 | $4.22 | +1.2% | ||
| 2018 | $4.17 | +18.8% | ||
| 2017 | $3.51 | -64.7% | ||
| 2016 | $9.94 | -16.5% | ||
| 2015 | $11.91 | +62.0% | ||
| 2014 | $7.35 | +306.1% | ||
| 2013 | $1.81 | +10.4% | ||
| 2012 | $1.64 | -7.9% | ||
| 2011 | $1.78 | +7.2% | ||
| 2010 | $1.66 | +17.7% | ||
| 2009 | $1.41 | +34.3% | ||
| 2008 | $1.05 | +25.0% | ||
| 2007 | $0.84 | -229.2% | ||
| 2006 | $-0.65 | -251.2% | ||
| 2005 | $0.43 | +72.0% | ||
| 2004 | $0.25 | -658.0% | ||
| 2003 | $-0.04 | -202.3% | ||
| 2002 | $0.04 | +34.8% | ||
| 2001 | $0.03 | -183.3% | ||
| 2000 | $-0.04 | -19.6% | ||
| 1999 | $-0.05 | +13.6% | ||
| 1998 | $-0.04 | +58.7% | ||
| 1997 | $-0.03 | +10.2% | ||
| 1996 | $-0.02 | -39.3% | ||
| 1995 | $-0.04 | -6.7% | ||
| 1994 | $-0.04 | — | ||
| 1992 | $-0.03 | +120.0% | ||
| 1991 | $-0.01 | -4.6% | ||
| 1990 | $-0.01 | — |
EPS (Diluted) values are taken from Gilead Sciences's reported income statements (10-Q quarterly and 10-K annual filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the date the filing was reported; YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
Analysis
2025's annual diluted EPS for Gilead Sciences (GILD) came in at $6.78 – surged 1684.2% year-over-year.
Over 2020–2025 (5 years), Gilead Sciences diluted EPS expanded at a +133.6% compound annual rate, with the latest reading among the more recent periods of the dataset.
Gilead Sciences diluted EPS plunged from $11.91 in 2015 to $6.78 in 2025, a 43.1% drawdown.
$11.91 stands as the all-time-high annual diluted EPS, posted in 2015, against a low of $-0.65 during 2006.
Among 8 Healthcare peers, Gilead Sciences (GILD) ranks 8th; the peer median for diluted EPS is $13.16.
Gilead Sciences EPS (Diluted) by Year
Gilead Sciences EPS (Diluted) 2025: $6.78
Gilead Sciences diluted EPS in 2025 was $6.78, surged 1684.2% from 2024.
Gilead Sciences EPS (Diluted) 2024: $0.38
Gilead Sciences diluted EPS in 2024 was $0.38, plunged 91.6% below 2023.
Gilead Sciences EPS (Diluted) 2023: $4.50
Gilead Sciences diluted EPS in 2023 was $4.50, grew 23.6% from 2022.
Gilead Sciences EPS (Diluted) 2022: $3.64
Gilead Sciences diluted EPS in 2022 was $3.64, declined 26.2% below 2021.
Gilead Sciences EPS (Diluted) 2021: $4.93
Gilead Sciences diluted EPS in 2021 was $4.93.
See more financial history for Gilead Sciences (GILD).
Sector peers — EPS (Diluted)
Companies in the same sector as Gilead Sciences, ranked by their latest diluted EPS.
| Company | EPS (Diluted) | Sector |
|---|---|---|
| Novo Nordisk A/S (NVO) | $23.03 | Healthcare |
| Eli Lilly and Company (LLY) | $22.95 | Healthcare |
| Amgen Inc. (AMGN) | $14.23 | Healthcare |
| UnitedHealth Group Incorporated (UNH) | $13.23 | Healthcare |
| AstraZeneca PLC (AZN) | $13.08 | Healthcare |
| Johnson & Johnson (JNJ) | $11.03 | Healthcare |
| Merck & Co., Inc. (MRK) | $7.28 | Healthcare |
| AbbVie Inc. (ABBV) | $2.37 | Healthcare |
Frequently asked questions
What is Gilead Sciences's diluted EPS?
- Latest reported diluted EPS for Gilead Sciences (GILD) is $6.77 (period ending December 31, 2025).
How has Gilead Sciences diluted EPS changed year-over-year?
- Gilead Sciences (GILD) diluted EPS changed +1684.2% year-over-year on the latest annual filing.
What is the long-term growth rate of Gilead Sciences diluted EPS?
- Gilead Sciences (GILD) diluted EPS compound annual growth rate is +133.6% over the most recent 5 years available.
When did Gilead Sciences diluted EPS hit its highest annual value?
- Gilead Sciences diluted EPS reached its highest annual value of $11.91 in 2015.
What was Gilead Sciences diluted EPS in 2024?
- Gilead Sciences (GILD) diluted EPS in 2024 was $0.38.
What was Gilead Sciences diluted EPS in 2025?
- Gilead Sciences (GILD) diluted EPS in 2025 was $6.78.
Metrics overview
Pick a metric for charts, filings, and peers — each row shows the latest TTM or annual value with year-over-year change.
Explore more
GILD Overview
Company profile, financial tools, and key metrics
GILD Revenue Counter
Earns $933.60 every second. See per minute, hour, and day.
GILD Earnings Counter
Earns $269.85 per second net profit. See per minute, hour, and day.
GILD Economic Scale
Exceeds Albania's GDP. Compare with world economies.
GILD What If Invested
What if you had invested $1,000? See historical returns from any date.
GILD How It Makes Money
Discover visual breakdown of $29.44B in revenue — where it comes from and where it goes.
GILD Stock Seasonality
Best and worst months to invest. Historical monthly returns heatmap.
GILD Price Target Scenarios
Model bear, base, and bull cases with EPS growth and exit P/E — pre-filled from analysts and history.
GILD Daily Price Character
Explosive · 48.7% historical win rate (green days). Streaks & record days.
GILD Buybacks
1.26% TTM buyback yield. Shareholder yield & SBC comparison.
GILD Stock Split History
5 splits on record. Dates, ratios, and cumulative multiple.
GILD Dividend Profile
Yield: 2.48%. Safety: 8/8. See full history.
GILD Dividend Calculator
How much dividend income would $1,000 have earned? Calculate from any date.
GILD Dividend Forecast
Project future income with DRIP, growth assumptions, and optional monthly contributions.